Supernus Announces First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Supernus Pharma (SUPN) Misses Q1 EPS by 13c
May 7, 2019 5:13 PM EDTSupernus Pharma (NASDAQ: SUPN) reported Q1 EPS of $0.34, $0.13 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $85.5 million versus the consensus estimate of $103.87 million.
Financial guidance reaffirmed
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
... More